Phase 2 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with esophageal squamous cell carcinoma (a specific type of oesophageal cancer), confirmed by laboratory testing of tissue samples
- People whose cancer has grown into nearby organs (known as T4 stage disease)
- People aged between 18 and 70 years old
- People who are reasonably active and able to carry out daily activities without significant limitation, based on a standard health scoring system (a score of 0 or 1 on the ECOG scale)
- People whose blood test results fall within acceptable ranges, including healthy levels of red blood cells, white blood cells, platelets, liver function, and kidney function (confirm with trial site for exact values)
Who may not be able to join:
- People who have previously received chemotherapy treatment
- People who have had a heart attack within the last three months
- People with a history of unstable chest pain (unstable angina), lung inflammation (interstitial pneumonia), scarring of the lungs (fibrotic lung disease), or severe emphysema
- People who currently have another type of cancer
- People who have an infection that is not under control
- People who are pregnant or currently breastfeeding
- People whose oesophagus had a hole or tear (perforation) at the time of their diagnosis
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +886-6-2353535
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall response rate of the treatment; Duration of response (DOR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.